Do plasma proteins distinguish between liposomes of varying charge density?

Journal of Proteomics

Volumn 75, Issue 6, 2012, Pages 1924-1932

  Capriotti, Anna Laura ^a   Caracciolo, Giulio ^a   Cavaliere, Chiara ^a   Foglia, Patrizia ^a   Pozzi, Daniela ^a   Samperi, Roberto ^a   Laganà, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cationic liposomes; Label free quantitative analysis; NanoLC MS MS; Plasma proteins; Proteomics

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C4B BINDING PROTEIN; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FIBRINOGEN; LEFETAMINE; LIPOSOME; NANOPARTICLE; PLASMA PROTEIN;

ADULT; ARTICLE; CELL MEMBRANE POTENTIAL; HUMAN; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; SURFACE CHARGE; TANDEM MASS SPECTROMETRY; ZETA POTENTIAL;

ADSORPTION; ADULT; APOLIPOPROTEINS; BLOOD PROTEINS; CATIONS; COMPLEMENT C4B-BINDING PROTEIN; FIBRINOGEN; HUMANS; LIPOSOMES; NANOPARTICLES; SURFACE PROPERTIES;

EID: 84857642491     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.01.003     Document Type: Article

References (33)

1. Al-Dosari M.S., Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 2009, 11:671-681.
2. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84:7413-7417.
3. Morille M., Passirani C., Vonarbourg A., Clavreul A., Benoit J.P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials 2008, 29:3477-3496.
4. Kamimura K., Suda T., Zhang G., Liu D. Advances in gene delivery systems. Pharm Med 2011, 25:293-306.
5. Abu Lila A.S., Ishida T., Kiwada H. Targeting anticancer drugs to tumor vasculature using cationic liposomes. Pharm Res 2010, 27:1171-1183.
6. Bhattacharya S., Bajaj A. Advances in gene delivery through molecular design of cationic lipids. Chem Commun 2009, 31:4632-4656.
7. Cedervall T., Lynch I., Foy M., Berggård T., Donnely S.C., Cagney G., et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 2007, 119:5854-5856.
8. Lundqvist M., Stigler J., Cedervall T., Elia G., Lynch I., Dawson K. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008, 105:14265-14270.
9. Lynch I., Dawson K.A. Protein-nanoparticle interactions. Nano Today 2008, 3:40-47.
10. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
11. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
12. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Baldelli Bombelli F., et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. JACS 2011, 133:2525-2534.
13. Monopoli M.P., Baldelli Bombelli F., Dawson K.A. Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol 2011, 6:11-12.
14. Walczyk D., Baldelli Bombelli F., Monopoli M.P., Lynch I., Dawson K.A. What the cell "sees" in bionanoscience. J Am Chem Soc 2010, 132:5761-5768.
15. Allen L.T., Tosetto M., Miller I., O'Connor D., Penney S.C., Lynch I., et al. Surface induced changes in protein adsorption and implications for cell-surface response. Biomaterials 2006, 27:3096-3108.
16. Capriotti A.L., Caracciolo G., Cavaliere C., Crescenzi C., Pozzi D., Laganà A. Shotgun proteomic analytical approach for studying proteins adsorbed onto liposome surface. Anal Bioanal Chem 2011, 401:1195-1202.
17. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.
18. Nefedov A.V., Gilski M.J., Sadygov R.G. Bioinformatics tools for mass spectrometry-based high-throughput quantitative proteomics platforms. Curr Proteomics 2011, 8:125-137.
19. Neilson K.A., Ali N.A., Muralidharan S., Mirzaei M., Mariani M., Assadourian G., et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011, 11:535-553.
20. Mueller L.N., Brusniak M.Y., Mani D.R., Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J Proteome Res 2008, 7:51-61.
21. Sandin M., Krogh M., Hansson K., Levander F. Generic workflow for quality assessment of quantitative label-free LC-MS analysis. Proteomics 2011, 11:1114-1124.
22. Lundgren D.H., Hwang S.I., Wu L., Han D.K. Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 2010, 7:39-53.
23. Katz E., Fon M., Eigenheer R.A., Phinney B.S., Fass J.N., Lin D., et al. A label-free differential quantitative mass spectrometry method for the characterization and identification of protein changes during citrus fruit development. Proteome Sci 2010, 8:68-86.
24. Yao X. Derivatization or not: a choice in quantitative proteomics. Anal Chem 2011, 83:4427-4439.
25. Caracciolo G., Pozzi D., Capriotti A.L., Marianecci C., Carafa M., Marchini C., et al. Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes. J Med Chem 2011, 54:4160-4171.
26. Simberg D., Park J.H., Karmali P.P., Zhang W.M., Merkulov S., McCrae K., et al. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 2009, 30:3926-3933.
27. Capriotti A.L., Caracciolo G., Caruso G., Cavaliere C., Pozzi D., Samperi R., et al. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal Bioanal Chem 2010, 398:2895-2903.
28. Searle B.C. Scaffold: a bioinformatic tool for validating MS/MS-based proteomics studies. Proteomics 2010, 10:1265-1269.
29. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:383-392.
30. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
31. Keller A., Eng J., Zhang N., Li X.J., Aebersold R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol Syst Biol 2005, 1:1-8.
32. Urbanija J., Tomšič N., Lokar M., Ambrožič A., Čučnik S., Rozmanc B., et al. Coalescence of phospholipid membranes as a possible origin of anticoagulant effect of serum proteins. Chem Phys Lipids 2007, 150:49-57.
33. Dergunov A.D., Taveirne J., Vanloo B., Caster H., Rosseneu M. Structural organization of lipid phase and protein-lipid interface in apolipoprotein-phospholipid recombinants: influence of cholesterol. Biochim Biophys Acta 1997, 1346:131-146.